Avita Medical
RCEL
73 hedge funds and large institutions have $82.6M invested in Avita Medical in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 8 closing their positions.
123% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 13
109% more call options, than puts
Call options by funds: $557K | Put options by funds: $266K
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
26% more capital invested
Capital invested by funds: $65.3M → $82.6M (+$17.3M)
9% more funds holding
Funds holding: 67 → 73 (+6)
1.17% more ownership
Funds ownership: 23.45% → 24.62% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.31M |
| 2 |
Goldman Sachs
New York
|
+$1.06M |
| 3 |
DIM
Delta Investment Management
San Francisco,
California
|
+$449K |
| 4 |
Millennium Management
New York
|
+$393K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$355K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$430K |
| 2 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$236K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$172K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$171K |
| 5 |
Morgan Stanley
New York
|
-$147K |
RCEL Hedge Fund Activity: Q4 2024 in Review
73 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2024, worth a combined $82.6M — up 26% from $65.3M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new RCEL positions and 8 closed out — a net gain of 6 holders — while 29 added to existing stakes and 13 trimmed.
The largest buyer was UBS Group, adding an estimated $1.31M. The largest seller was Jane Street, cutting an estimated $430K.
- 73 institutional investors held Avita Medical (RCEL) as of Q4 2024, up from 67 in Q3 2024.
- Funds reported $82.6M of Avita Medical stock for Q4 2024, up 26% quarter-over-quarter.
- 14 funds opened new Avita Medical positions in Q4 2024 and 8 closed out, a net change of +6 holders.
- The largest Avita Medical buyer in Q4 2024 was UBS Group, an estimated $1.31M added.
- The largest Avita Medical seller in Q4 2024 was Jane Street, an estimated $430K sold.
Based on aggregated 13F filings for Q4 2024.